Key Takeaways Docusign's first-quarter billings missed estimates, and it lowered its full-year billings outlook.The ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Is ENPH stock a worthwhile purchase following such a considerable drop? This steep decrease for Enphase Energy stands out ...

The most recent trading session ended with DocuSign (DOCU ... revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks ...

The most recent trading session ended with DocuSign (DOCU) standing at $90.27 ... that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, ...

On Friday, RBC Capital analysts maintained their Sector Perform rating and a $90.00 price target for Docusign Inc ... and led to a significant decline in the stock’s after-hours trading.

On a year-to-date basis, DOCU has gained nearly 4 %, outperforming the broader S&P 500 Index, which rose 1.51% during the ...

DocuSign has experienced a notable decline in its stock price, dropping by 15.61% over the past week. This movement comes amidst a series of analyst reports maintaining a ‘Hold ...

which showed mixed results and led to a significant decline in the stock’s after-hours trading. According to InvestingPro data, the stock is currently trading below its Fair Value, despite showing ...